Clinical Trial Update: Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Lantus for Type 2 diabetes management has been terminated. The study was sponsored by Sanofi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes | Phase 4 | Status: TERMINATED